@Eyeman
Gmv is not the only illiquid spec that dropped in price; here are 2 e.g.,
sp last 6-12months,
Spt, 44c-$2 -42x
Fod, 6.6 - 21c, 6.3
Every punter is in a sour-dough mood.
Nothing can cure sentiments except sp goes up.
Gmv
Noone incl Yacov had anticipated the china delays and untimely china PI passing, after change of Cfda to Nmpa setup, which cause us additional delay.
(Does he prefer sp to go up or down?
Btw, his loan/$10m was converted to share at 33c)
UK hospitals @265000 pounds/yr, look good, very good.
It is obvious GMV tech are Best of Breeds,and no other competitors come close
China MOUs per Update are still intact (Beijing S.Lake and S Boletong , millions of Prizma units, $Billion dollar).
Either you believe, or not.
I still believe in the Gmv story,and can afford to wait another 3-4 quarters.
I have some spare lunch money to top up.
Take care.
- Forums
- ASX - By Stock
- GMV
- Ann: Company Update
Ann: Company Update, page-139
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online